ANI Pharmaceuticals (NASDAQ:ANIP) Rating Lowered to Sell at StockNews.com
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Thursday. Other research analysts have also issued reports about the company. HC Wainwright reiterated a “buy” rating and issued a $94.00 price objective on shares of ANI […]
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Thursday. Other research analysts have also issued reports about the company. HC Wainwright reiterated a “buy” rating and issued a $94.00 price objective on shares of ANI […]
